EMA and the Heads of Medicines Agencies released their annual “AI Observatory” report, which is effectively a regulatory horizon scan of where AI is already showing up in submissions, regulator operations, and EU-funded regulatory science. A key value of this report is that it doesn’t just talk about AI—it documents where regulators see real activity and where the gaps remain (notably: “regulatory-grade” model validation and auditability).